TABLE 1.
Patient Demographics
| Variable | No Pre-Eclampsia (n=22) | Pre-Eclampsia (n=17) | p-value |
|---|---|---|---|
| Age at Delivery (years) | 29.3 (5.9) | 27.4 (7.4) | 0.18 |
| Gravidity (# pregnancies) | 3.1 (1.9) | 2.6 (2.2) | 0.58 |
| Race = African American (n,%) | 17 (77) | 13 (77) | 1 |
| Race = White (n,%) | 5 (23) | 4 (24) | 1 |
| Pre-pregnancy Weight (pounds) | 200 (59.9) | 177 (59.6) | 0.47 |
| Tobacco Use (n,%) | 4 (18) | 4 (24) | 0.71 |
| Chronic Hypertension (n,%) | 5 (23) | 5 (29) | 0.72 |
| Diabetes (n,%) | 2 (9) | 3 (18) | 0.64 |
| Gestational DM (n,%) | 4 (18) | 1 (6) | 0.36 |
| Cesarean Delivery (n,%) | 11 (50) | 11 (65) | 0.59 |
| Birth Weight (grams) | 3273 (775) | 1875 (984) | 0.26 |
| Gestational Age at Delivery (weeks) | 38.7 (2.6) | 32.1 (4.7) | <0.001 |
| Systolic Blood Pressure (mmHg) | 130 (14.7) | 151 (27.1) | 0.004 |
| Diastolic Blood Pressure (mmHg) | 82 (8.7) | 97 (20.1) | 0.003 |
| Creatinine at delivery (mg/dl) (10 no pre-e, 15 pre-e) | 0.57 (0.10) | 0.70 (0.20) | 0.08 |
| BNP ( 15 no pre-e, 9 pre-e) | 525 (345) | 888 (510) | 0.049 |
| Diagnosis Data | |||
| Diagnosed Prior to Delivery (n,%) | 5 (23) | 4 (24) | 1.0 |
| Post-partum Day | 40.7 (43.7) | 15.6 (46.2) | 0.09 |
| Medical Therapy Initiated After Diagnosis (n,%) | |||
| Furosemide | 12(55) | 12(71) | 0.3 |
| Other Diuretic | 1(5) | 2(12) | 0.6 |
| Spironolactone | 4(18) | 5(29) | 0.5 |
| Beta Blocker | 17(77) | 15(88) | 0.4 |
| Calcium Channel Blocker | 3(14) | 2(12) | 1 |
| Digoxin | 5(23) | 3(18) | 1 |
| ACEI/ARB | 18(82) | 16(94) | 0.4 |
| Anticoagulation | 11(50) | 5(29) | 0.3 |
| Aspirin | 6(27) | 3(18) | 0.7 |
| Warfarin | 7(32) | 2(12) | 0.3 |
Values reported as mean(SD) except where indicated